IL232463A0 - Antibiotic history of 2-oxo-oxazolidine-3,5-diyl - Google Patents

Antibiotic history of 2-oxo-oxazolidine-3,5-diyl

Info

Publication number
IL232463A0
IL232463A0 IL232463A IL23246314A IL232463A0 IL 232463 A0 IL232463 A0 IL 232463A0 IL 232463 A IL232463 A IL 232463A IL 23246314 A IL23246314 A IL 23246314A IL 232463 A0 IL232463 A0 IL 232463A0
Authority
IL
Israel
Prior art keywords
oxazolidin
diyl
oxo
antibiotic derivatives
antibiotic
Prior art date
Application number
IL232463A
Other languages
English (en)
Hebrew (he)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of IL232463A0 publication Critical patent/IL232463A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Detergent Compositions (AREA)
IL232463A 2011-11-08 2014-05-05 Antibiotic history of 2-oxo-oxazolidine-3,5-diyl IL232463A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2011054968 2011-11-08
PCT/IB2012/056236 WO2013068948A1 (en) 2011-11-08 2012-11-07 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Publications (1)

Publication Number Publication Date
IL232463A0 true IL232463A0 (en) 2014-06-30

Family

ID=47258051

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232463A IL232463A0 (en) 2011-11-08 2014-05-05 Antibiotic history of 2-oxo-oxazolidine-3,5-diyl

Country Status (21)

Country Link
US (1) US9079922B2 (OSRAM)
EP (1) EP2776431B1 (OSRAM)
JP (1) JP6030146B2 (OSRAM)
KR (1) KR20140096337A (OSRAM)
AR (1) AR088691A1 (OSRAM)
AU (1) AU2012335207B2 (OSRAM)
BR (1) BR112014011064A8 (OSRAM)
CA (1) CA2854264A1 (OSRAM)
CL (1) CL2014001154A1 (OSRAM)
ES (1) ES2581056T3 (OSRAM)
HK (1) HK1202288A1 (OSRAM)
IL (1) IL232463A0 (OSRAM)
IN (1) IN2014CN04126A (OSRAM)
MX (1) MX344529B (OSRAM)
PH (1) PH12014500831A1 (OSRAM)
PL (1) PL2776431T3 (OSRAM)
RU (1) RU2616609C2 (OSRAM)
SG (1) SG11201401710PA (OSRAM)
TW (1) TWI594996B (OSRAM)
WO (1) WO2013068948A1 (OSRAM)
ZA (1) ZA201404176B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010041194A1 (en) 2008-10-07 2010-04-15 Actelion Pharmaceuticals Ltd Tricyclic oxazolidinone antibiotic compounds
AU2014255326B2 (en) 2013-04-16 2018-09-13 Idorsia Pharmaceuticals Ltd Antibacterial biaromatic derivatives
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
MA41169A (fr) 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
GB201602235D0 (en) * 2016-02-08 2016-03-23 Redx Pharma Plc Antibacterial compounds
JP2019504850A (ja) * 2016-02-08 2019-02-21 レデックス ファーマ ピーエルシーRedx Pharma Plc 複素環式化合物、特に2−オキソ−4,4,5,5,6,6,7,7−オクタヒドロベンズオキサゾール誘導体、および抗菌化合物としてのこれらの使用
EP3414246A1 (en) * 2016-02-08 2018-12-19 Redx Pharma PLC Antibacterial compounds
EA201892815A1 (ru) 2016-06-08 2019-05-31 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Новые антибактериальные соединения
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
PL3634968T3 (pl) * 2017-06-08 2023-07-31 Bugworks Research, Inc. Związki heterocykliczne użyteczne jako środki przeciwbakteryjne oraz sposób ich wytwarzania
ES2952989T3 (es) 2017-11-29 2023-11-07 Bugworks Res Inc Compuestos heterocíclicos antibacterianos y su síntesis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
CA1006521A (en) 1972-12-18 1977-03-08 Minoru Sugita Piperazine derivatives and process for preparing them
GB1598915A (en) 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
CS274601B2 (en) 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS62205060A (ja) 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd 8位置換キノロンカルボン酸誘導体
AU618235B2 (en) 1986-03-31 1991-12-19 Sankyo Company Limited Quinoline-3-carboxylic acid derivatives, their preparation and use
JP2631854B2 (ja) 1987-12-23 1997-07-16 藤本製薬株式会社 新規な1,8−ナフチリジン誘導体
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
AU2003244235A1 (en) 2002-06-28 2004-01-19 Kaneka Corporation Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
CA2529347C (en) * 2003-04-30 2011-09-06 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
NZ547382A (en) * 2003-12-18 2009-11-27 Morphochem Ag Komb Chemie Oxazolidinone-quinolone hybrid antibiotics
AU2005279050A1 (en) 2004-07-30 2006-03-09 Centre National De La Recherche Scientifique (Cnrs) Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, and the synthesis and uses thereof as antibacterial agents
ATE435693T1 (de) 2004-09-01 2009-07-15 Ubitrak Inc System zum identifizieren und zählen von spieljetons
US20090156577A1 (en) 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
EP2007377A4 (en) 2006-04-06 2011-08-17 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
AU2007318901B2 (en) * 2006-11-10 2013-03-14 Actelion Pharmaceuticals Ltd 5-hydroxymethyl-oxazolidin-2-one derivatives
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
PL2245028T3 (pl) * 2007-12-18 2012-07-31 Actelion Pharmaceuticals Ltd Pochodne 5-aminocyklilometyloksazolidyn-2-onu
RU2501799C2 (ru) * 2008-02-22 2013-12-20 Актелион Фармасьютикалз Лтд Поизводные оксазолидинона
WO2010041194A1 (en) 2008-10-07 2010-04-15 Actelion Pharmaceuticals Ltd Tricyclic oxazolidinone antibiotic compounds
BRPI0920870A2 (pt) 2008-10-10 2018-06-26 Actelion Pharmaceuticals Ltd antibióticos de oxazolidinila.
EP2346862B1 (en) * 2008-10-10 2012-09-12 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
TW201121965A (en) 2009-09-28 2011-07-01 Lg Life Sciences Ltd Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis
CN101792443A (zh) 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途

Also Published As

Publication number Publication date
PH12014500831A1 (en) 2019-08-07
HK1202288A1 (en) 2015-09-25
BR112014011064A2 (pt) 2017-06-13
SG11201401710PA (en) 2014-09-26
KR20140096337A (ko) 2014-08-05
US9079922B2 (en) 2015-07-14
ES2581056T3 (es) 2016-08-31
MX344529B (es) 2016-12-19
AU2012335207A1 (en) 2014-07-03
TWI594996B (zh) 2017-08-11
US20150051188A1 (en) 2015-02-19
PL2776431T3 (pl) 2016-11-30
AR088691A1 (es) 2014-06-25
CN103917539A (zh) 2014-07-09
RU2616609C2 (ru) 2017-04-18
TW201326166A (zh) 2013-07-01
EP2776431A1 (en) 2014-09-17
BR112014011064A8 (pt) 2017-12-26
CA2854264A1 (en) 2013-05-16
CL2014001154A1 (es) 2014-09-12
IN2014CN04126A (OSRAM) 2015-07-10
JP6030146B2 (ja) 2016-11-24
AU2012335207B2 (en) 2017-05-25
RU2014123109A (ru) 2015-12-20
WO2013068948A1 (en) 2013-05-16
JP2014532754A (ja) 2014-12-08
MX2014005637A (es) 2014-06-23
EP2776431B1 (en) 2016-05-04
ZA201404176B (en) 2016-05-25

Similar Documents

Publication Publication Date Title
IL232463A0 (en) Antibiotic history of 2-oxo-oxazolidine-3,5-diyl
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
SI2694508T1 (sl) Soli substituiranega 2,3-dihidroimidazo(1,2-C)kinazolina
AP3336A (en) Fluoro-pyridinone derivatives useful as antibacterial agents
AP2013007254A0 (en) 4-Aryl-N-phenyl-1,3,5,-triazin-2-amines containinga sulfoximine group
SG10201601802YA (en) Dispiropyrrolidine derivatives
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
IL247636A0 (en) History of heteroaryl piperidine
ZA201404074B (en) 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
ZA201306229B (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines
EP2569324A4 (en) Aminoglycoside DERIVATIVES
ZA201302651B (en) 1,2,4-triazolone derivative
ZA201302112B (en) 1,4-oxazepane derivatives
IL233001A0 (en) New iso-ergoline histories
SI2766342T1 (sl) Derivati fenil-gvanidina
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
PL2785708T3 (pl) Owadobójcze pochodne triazynonu
EP2665701A2 (en) Diazeniumdiolate derivatives
HK1186730A (en) 1,4-oxazepane derivatives
GB201119958D0 (en) Antibacterial derivatives
GB201119961D0 (en) Antibacterial derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives
AU2011903213A0 (en) Watertow 1
AU2011903555A0 (en) Rumentek 5 Sep11
AU2011904925A0 (en) Watertow 2